☰

Tiffany J Petrisko - Publications

Affiliations: 
University of California, Irvine, Irvine, CA 
Area:
Neuroimmune, Alzheimer’s, complement
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Schartz ND, Liang HY, Carvalho K, Chu SH, Mendoza-Arvilla A, Petrisko TJ, Gomez-Arboledas A, Mortazavi A, Tenner AJ. C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer's disease mouse model. Nature Communications. 15: 7028. PMID 39147742 DOI: 10.1038/s41467-024-51163-6  0.587
2023 Petrisko TJ, Gargus M, Chu SH, Selvan P, Whiteson KL, Tenner AJ. Influence of complement protein C1q or complement receptor C5aR1 on gut microbiota composition in wildtype and Alzheimer's mouse models. Journal of Neuroinflammation. 20: 211. PMID 37726739 DOI: 10.1186/s12974-023-02885-9  0.541
2023 Schartz ND, Liang HY, Carvalho K, Chu SH, Mendoza-Arvilla A, Petrisko TJ, Gomez-Arboledas A, Mortazavi A, Tenner AJ. C5aR1 antagonism suppresses inflammatory glial gene expression and alters cellular signaling in an aggressive Alzheimer's model. Biorxiv : the Preprint Server For Biology. PMID 37662399 DOI: 10.1101/2023.08.22.554306  0.575
2022 Gomez-Arboledas A, Carvalho K, Balderrama-Gutierrez G, Chu SH, Liang HY, Schartz ND, Selvan P, Petrisko TJ, Pan MA, Mortazavi A, Tenner AJ. C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer's disease. Acta Neuropathologica Communications. 10: 116. PMID 35978440 DOI: 10.1186/s40478-022-01416-6  0.546
2022 Carvalho K, Schartz ND, Balderrama-Gutierrez G, Liang HY, Chu SH, Selvan P, Gomez-Arboledas A, Petrisko TJ, Fonseca MI, Mortazavi A, Tenner AJ. Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression. Journal of Neuroinflammation. 19: 178. PMID 35820938 DOI: 10.1186/s12974-022-02539-2  0.566
2021 Petrisko TJ, Gomez-Arboledas A, Tenner AJ. Complement as a powerful "influencer" in the brain during development, adulthood and neurological disorders. Advances in Immunology. 152: 157-222. PMID 34844709 DOI: 10.1016/bs.ai.2021.09.003  0.524
2021 Petrisko TJ, Konat GW. Peripheral viral challenge increases c-fos level in cerebral neurons. Metabolic Brain Disease. PMID 34406561 DOI: 10.1007/s11011-021-00819-z  0.591
2020 Petrisko TJ, Bloemer J, Pinky PD, Srinivas S, Heslin RT, Du Y, Setti SE, Hong H, Suppiramaniam V, Konat GW, Reed MN. Neuronal CXCL10/CXCR3 Axis Mediates the Induction of Cerebral Hyperexcitability by Peripheral Viral Challenge. Frontiers in Neuroscience. 14: 220. PMID 32265633 DOI: 10.3389/Fnins.2020.00220  0.653
2019 Petrisko TJ, Konat GW. Peripheral viral challenge exacerbates experimental autoimmune encephalomyelitis. Metabolic Brain Disease. PMID 30637619 DOI: 10.1007/S11011-019-0383-Y  0.588
2017 Petrisko T, Konat G. Peripheral viral challenge triggers hippocampal production of inflammatory proteins. Metabolic Brain Disease. 32: 1249-1254. PMID 28523567 DOI: 10.1007/S11011-017-0030-4  0.618
2016 Hunsberger HC, Wang D, Petrisko TJ, Alhowail A, Setti SE, Suppiramaniam V, Konat GW, Reed MN. Peripherally restricted viral challenge elevates extracellular glutamate and enhances synaptic transmission in the hippocampus. Journal of Neurochemistry. PMID 27168075 DOI: 10.1111/Jnc.13665  0.602
Show low-probability matches.